119 related articles for article (PubMed ID: 15226097)
1. The ability of three global plasma assays to recognize thrombophilia.
Andresen MS; Abildgaard U; Liestøl S; Sandset PM; Mowinckel MC; Ødegaard OR; Larsen ML; Diep LM
Thromb Res; 2004; 113(6):411-7. PubMed ID: 15226097
[TBL] [Abstract][Full Text] [Related]
2. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
Favaloro EJ; Mirochnik O; McDonald D
Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
4. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
5. Detection of high-risk thrombophilia with an automated, global test: the Coagulation Inhibitor Potential assay.
Réger B; Losonczy H; Nagy Á; Péterfalvi Á; Mózes R; Pótó L; Farkas N; Kovács GL; Miseta A; Hussain A; Tóth O
Blood Coagul Fibrinolysis; 2018 Jul; 29(5):435-441. PubMed ID: 29782332
[TBL] [Abstract][Full Text] [Related]
6. Coagulation Inhibitor Potential: a study of assay variables.
Andresen MS; Abildgaard U
Thromb Res; 2005; 115(6):519-26. PubMed ID: 15792684
[TBL] [Abstract][Full Text] [Related]
7. Protein C global assay in the evaluation of women with idiopathic pregnancy loss.
Sarig G; Lanir N; Hoffman R; Brenner B
Thromb Haemost; 2002 Jul; 88(1):32-6. PubMed ID: 12152673
[TBL] [Abstract][Full Text] [Related]
8. Pro CR global: an effective screening test for thrombophilia.
Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
[TBL] [Abstract][Full Text] [Related]
9. Quality assurance issues and interpretation of assays.
Mackie I; Cooper P; Kitchen S
Semin Hematol; 2007 Apr; 44(2):114-25. PubMed ID: 17433904
[TBL] [Abstract][Full Text] [Related]
10. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
Toulon P; Perez P; Rapp J; Adda R
Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
Toulon P; Adda R; Perez P
Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
[TBL] [Abstract][Full Text] [Related]
13. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
Toulon P; Perez P
Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new venom-based clotting assay of protein C.
Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Schöni R; Quehenberger P; Wu JR; Wilmer M
Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
[TBL] [Abstract][Full Text] [Related]
17. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study.
Toulon P; Smirnov M; Triscott M; Safa O; Biguzzi E; Bouziane K; Tripodi A
Thromb Res; 2009 May; 124(1):137-43. PubMed ID: 19157524
[TBL] [Abstract][Full Text] [Related]
18. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.
Vig S; Chitolie A; Bevan D; Dormandy J; Thompson MM; Halliday A
Br J Surg; 2006 May; 93(5):577-81. PubMed ID: 16607693
[TBL] [Abstract][Full Text] [Related]
20. ProC global: a new automated screening assay for the evaluation of total function of the protein C system.
Dragoni F; Tormene D; Simioni P; Arcieri P; Avvisati G; Girolami A
Clin Appl Thromb Hemost; 2001 Oct; 7(4):351-5. PubMed ID: 11697723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
